» Articles » PMID: 19582506

The FLARE Intraoperative Near-infrared Fluorescence Imaging System: a First-in-human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2009 Jul 8
PMID 19582506
Citations 304
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Invisible NIR fluorescent light can provide high sensitivity, high-resolution, and real-time image-guidance during oncologic surgery, but imaging systems that are presently available do not display this invisible light in the context of surgical anatomy. The FLARE imaging system overcomes this major obstacle.

Methods: Color video was acquired simultaneously, and in real-time, along with two independent channels of NIR fluorescence. Grayscale NIR fluorescence images were converted to visible "pseudo-colors" and overlaid onto the color video image. Yorkshire pigs weighing 35 kg (n = 5) were used for final preclinical validation of the imaging system. A six-patient pilot study was conducted in women undergoing sentinel lymph node (SLN) mapping for breast cancer. Subjects received (99m)Tc-sulfur colloid lymphoscintigraphy. In addition, 12.5 microg of indocyanine green (ICG) diluted in human serum albumin (HSA) was used as an NIR fluorescent lymphatic tracer.

Results: The FLARE system permitted facile positioning in the operating room. NIR light did not change the look of the surgical field. Simultaneous pan-lymphatic and SLN mapping was demonstrated in swine using clinically available NIR fluorophores and the dual NIR capabilities of the system. In the pilot clinical trial, a total of nine SLNs were identified by (99m)Tc- lymphoscintigraphy and nine SLNs were identified by NIR fluorescence, although results differed in two patients. No adverse events were encountered.

Conclusions: We describe the successful clinical translation of a new NIR fluorescence imaging system for image-guided oncologic surgery.

Citing Articles

Fluorescence Lifetime Endoscopy with a Nanosecond Time-Gated CAPS Camera with IRF-Free Deep Learning Method.

Iranian P, Lapauw T, Van den Dries T, Sahakian S, Wuts J, Jacobs V Sensors (Basel). 2025; 25(2).

PMID: 39860819 PMC: 11768465. DOI: 10.3390/s25020450.


[Evidence for the extent and oncological benefit of lymphadenectomy for esophageal cancer].

Krauss D, Schmidt T, Bruns C, Fuchs H Chirurgie (Heidelb). 2025; .

PMID: 39820665 DOI: 10.1007/s00104-024-02215-6.


Advances in Natural-Product-Based Fluorescent Agents and Synthetic Analogues for Analytical and Biomedical Applications.

Joshi S, Moody A, Budthapa P, Gurung A, Gautam R, Sanjel P Bioengineering (Basel). 2025; 11(12.

PMID: 39768110 PMC: 11727039. DOI: 10.3390/bioengineering11121292.


Temporal dynamics of fluorescence and photoacoustic signals of a Cetuximab-IRDye800 conjugate in EGFR-overexpressing tumors.

Saad M, Allen D, Sweeney A, Xavierselvan M, Mallidi S, Hasan T bioRxiv. 2024; .

PMID: 39677759 PMC: 11642854. DOI: 10.1101/2024.11.26.625469.


Recent advances of photoresponsive nanomaterials for diagnosis and treatment of acute kidney injury.

Yao S, Wang Y, Mou X, Yang X, Cai Y J Nanobiotechnology. 2024; 22(1):676.

PMID: 39501286 PMC: 11536863. DOI: 10.1186/s12951-024-02906-6.


References
1.
Parungo C, Soybel D, Colson Y, Kim S, Ohnishi S, Degrand A . Lymphatic drainage of the peritoneal space: a pattern dependent on bowel lymphatics. Ann Surg Oncol. 2006; 14(2):286-98. PMC: 2515477. DOI: 10.1245/s10434-006-9044-6. View

2.
Fujiwara M, Mizukami T, Suzuki A, Fukamizu H . Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. J Plast Reconstr Aesthet Surg. 2008; 62(10):e373-8. DOI: 10.1016/j.bjps.2007.12.074. View

3.
Liu F, Bloch N, Bhushan K, De Grand A, Tanaka E, Solazzo S . Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Mol Imaging. 2009; 7(4):175-86. PMC: 2768041. View

4.
Kim S, Lim Y, Soltesz E, De Grand A, Lee J, Nakayama A . Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol. 2003; 22(1):93-7. PMC: 2346610. DOI: 10.1038/nbt920. View

5.
Knapp D, Adams L, Degrand A, Niles J, Ramos-Vara J, Weil A . Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol. 2007; 52(6):1700-8. PMC: 2385787. DOI: 10.1016/j.eururo.2007.07.007. View